A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Update Il y a 5 ans
Reference: NCT01473901

Woman and Man

Extract

This clinical study will assess the doses of BKM120 appropriate for patients with newly diagnosed glioblastoma when given in combination with radiotherapy and temozolomide.


Inclusion criteria

  • Glioblastoma


Links